Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-07-03
1993-04-13
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548186, 548187, C07D27714, A61K 31425
Patent
active
052023427
ABSTRACT:
This invention relates to the compounds of the formula [I] and salts thereof, which are useful for treatment of liver disorders, ##STR1## wherein X is oxygen or sulfur;
REFERENCES:
patent: 4148800 (1979-04-01), Schubert
Johnston J. Org. Chem. 29, 2442(1964).
Soai, Heterocycles, 22 (12) 2827 (1984).
Yoshimitsu Nagao et al, "Syntheses of rac)3-Substituted 4-Methoxycarbonyl-1,3-thiazolidine-2-thiones via Rearrangement of a Substituted Group from exo-S to N in (rac)2-Substituted Thio-4-methoxycarbonyl-.DELTA..sup.2 -1,3-thiazolines.sup.1,2)", 1988; pp. 495-508, Chem.Pharm.Bull.36(2).
Regina Zibuck et al, "Total Synthesis of (+)-Latrunculin B", 1986, 2451-2453, J. Am.Chem.Soc. 108.
Kawashima Yoichi
Mita Shiro
Morita Takakazu
Gerstl Robert
Santen Pharmaceutical Co. Ltd.
LandOfFree
N-alkyl thiazolidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-alkyl thiazolidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-alkyl thiazolidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1155664